Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|November 14, 2023
Proof of concept of triple COMBI therapy to prohibit MPN progression to AMLHans Carl Hasselbalch, Vibe Skov, Lasse Kjaer, et al.
Ugeskrift for Laeger|February 7, 2008
[Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia]Ole Weis Bjerrum, Inge Høgh Dufva, Jesper Stentoft, et al.
Frontiers in Neurology|September 29, 2023
Elevated white blood cell counts in ischemic stroke patients are associated with increased mortality and new vascular eventsThao Phuong Vo, Marie Hvelplund Kristiansen, Hans Carl Hasselbalch, et al.
Eclinicalmedicine|October 22, 2020
Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degenerationCharlotte Liisborg, Marie Krogh Nielsen, Hans Carl Hasselbalch, et al.
British Journal of Haematology|February 23, 2007
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disordersThomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosisThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2008
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Ugeskrift for Laeger|June 10, 2020
[Myeloproliferative neoplasms and chronic inflammatory bowel disease]Heidi Hesselø, Marie Bak, Trine Boysen, et al.
Pageof 16